Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

KRSA holding history

Korsana Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRSA overviewAll 13F holders of KRSAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KRSA by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1−100.0%Sold outHolders
Q1 20261$2<0.1%00.0%UnchangedHolders
Q4 20251$2<0.1%−648−99.8%ReducedHolders
Q3 2025649$1.49K<0.1%00.0%UnchangedHolders
Q2 2025649$1.89K<0.1%00.0%UnchangedHolders
Q1 2025649$1.62K<0.1%00.0%UnchangedHolders
Q4 2024649$2.09K<0.1%00.0%UnchangedHolders
Q3 2024649$1.68K<0.1%00.0%UnchangedHolders
Q2 2024649$1.49K<0.1%00.0%UnchangedHolders
Q1 2024649$2.08K<0.1%−49−7.0%ReducedHolders
Q4 2023698$2.34K<0.1%−125−15.2%ReducedHolders
Q3 2023823$2.82K<0.1%00.0%UnchangedHolders
Q2 2023823$3.39K<0.1%+221+36.7%AddedConverted for a 1-for-20 splitHolders
Q1 202312,040$5.22K<0.1%+8,751+266.1%AddedHolders
Q4 20223,289$2.16K<0.1%−109−3.2%ReducedHolders
Q3 20223,398$3.00K<0.1%−1,853−35.3%ReducedHolders
Q2 20225,251$3.00K<0.1%−33,934−86.6%ReducedHolders
Q1 202239,185$43.0K<0.1%−33,680−46.2%ReducedHolders
Q4 202172,865$125.0K<0.1%−1,643−2.2%ReducedHolders
Q3 202174,508$229.0K<0.1%+4,353+6.2%AddedHolders
Q2 202170,155$274.0K<0.1%+32,374+85.7%AddedHolders
Q1 202137,781$105.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.